BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 9026031)

  • 1. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats.
    Sakai H; Takeoka S; Park SI; Kose T; Nishide H; Izumi Y; Yoshizu A; Kobayashi K; Tsuchida E
    Bioconjug Chem; 1997; 8(1):23-30. PubMed ID: 9026031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical properties of hemoglobin vesicles as red cell substitutes.
    Sakai H; Hamada K; Takeoka S; Nishide H; Tsuchida E
    Biotechnol Prog; 1996; 12(1):119-25. PubMed ID: 8845102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats.
    Sakai H; Masada Y; Horinouchi H; Yamamoto M; Ikeda E; Takeoka S; Kobayashi K; Tsuchida E
    Crit Care Med; 2004 Feb; 32(2):539-45. PubMed ID: 14758176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous microvascular responses to hemodilution with a red cell substitute consisting of polyethyleneglycol-modified vesicles encapsulating hemoglobin.
    Sakai H; Tsai AG; Kerger H; Park SI; Takeoka S; Nishide H; Tsuchida E; Intaglietta M
    J Biomed Mater Res; 1998 Apr; 40(1):66-78. PubMed ID: 9511100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
    Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
    Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
    Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
    Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheological properties of hemoglobin vesicles (artificial oxygen carriers) suspended in a series of plasma-substitute solutions.
    Sakai H; Sato A; Takeoka S; Tsuchida E
    Langmuir; 2007 Jul; 23(15):8121-8. PubMed ID: 17567054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene glycol)-conjugated human serum albumin including iron porphyrins: surface modification improves the O2-transporting ability.
    Huang Y; Komatsu T; Wang RM; Nakagawa A; Tsuchida E
    Bioconjug Chem; 2006; 17(2):393-8. PubMed ID: 16536471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
    Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
    Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
    Sakai H; Tsuchida E
    Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: degradation of HbV and erythropoiesis in a rat spleen for 2 weeks.
    Sakai H; Horinouchi H; Yamamoto M; Ikeda E; Takeoka S; Takaori M; Tsuchida E; Kobayashi K
    Transfusion; 2006 Mar; 46(3):339-47. PubMed ID: 16533274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: objective comparison between cellular and acellular types.
    Sakai H; Yuasa M; Onuma H; Takeoka S; Tsuchida E
    Bioconjug Chem; 2000; 11(1):56-64. PubMed ID: 10639086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model.
    Sakai H; Horinouchi H; Tsuchida E; Kobayashi K
    Shock; 2009 May; 31(5):507-14. PubMed ID: 18827742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models.
    Conover CD; Linberg R; Shum KL; Shorr RG
    Artif Cells Blood Substit Immobil Biotechnol; 1999 Mar; 27(2):93-107. PubMed ID: 10092932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased viscosity of hemoglobin-based oxygen carriers retards NO-binding when perfused through narrow gas-permeable tubes.
    Sakai H; Okuda N; Takeoka S; Tsuchida E
    Microvasc Res; 2011 Mar; 81(2):169-76. PubMed ID: 21167845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size-selective protein adsorption to polystyrene surfaces by self-assembled grafted poly(ethylene glycols) with varied chain lengths.
    Lazos D; Franzka S; Ulbricht M
    Langmuir; 2005 Sep; 21(19):8774-84. PubMed ID: 16142960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion model.
    Izumi Y; Sakai H; Kose T; Hamada K; Takeoka S; Yoshizu A; Horinouchi H; Kato R; Nishide H; Tsuchida E; Kobayashi K
    ASAIO J; 1997; 43(4):289-97. PubMed ID: 9242942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O2-binding albumin thin films: solid membranes of poly(ethylene glycol)-conjugated human serum albumin incorporating iron porphyrin.
    Nakagawa A; Komatsu T; Huang Y; Lu G; Tsuchida E
    Bioconjug Chem; 2007; 18(5):1673-7. PubMed ID: 17696490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters.
    Wettstein R; Tsai AG; Erni D; Winslow RM; Intaglietta M
    Crit Care Med; 2003 Jun; 31(6):1824-30. PubMed ID: 12794426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving microcirculation is more effective than substitution of red blood cells to correct metabolic disorder in experimental hemorrhagic shock.
    Wettstein R; Tsai AG; Erni D; Lukyanov AN; Torchilin VP; Intaglietta M
    Shock; 2004 Mar; 21(3):235-40. PubMed ID: 14770036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.